151
|
Assessing the mycotoxigenic threat of necrotrophic pathogens of wheat. Mycotoxin Res 2011; 27:231-7. [DOI: 10.1007/s12550-011-0108-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2011] [Revised: 07/26/2011] [Accepted: 07/27/2011] [Indexed: 11/27/2022]
|
152
|
Baldwin T, Riley R, Zitomer N, Voss K, Coulombe Jr. R, Pestka J, Williams D, Glenn A. The current state of mycotoxin biomarker development in humans and animals and the potential for application to plant systems. WORLD MYCOTOXIN J 2011. [DOI: 10.3920/wmj2011.1292] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Filamentous fungi that contaminate livestock feeds and human food supply often produce toxigenic secondary metabolites known as mycotoxins. Among the hundreds of known mycotoxins, aflatoxins, deoxynivalenol, fumonisins, ochratoxin A and zearalenone are considered the most commercially important. Intense research on these mycotoxins, especially aflatoxin, has resulted in the development of 'biomarkers' used to link exposure to disease risk. In the case of aflatoxin this effort has led to the discovery of both exposure and mechanism-based biomarkers, which have proven essential for understanding aflatoxin's potential for causing disease in humans, including subtle effects on growth and immune response. Fumonisin biomarkers have also been used extensively in farm and laboratory animals to study the fumonisin-induced disruption of cellular and systemic physiology which leads to disease. This review summarises the status of mycotoxin biomarker development in humans and animals for the commercially important mycotoxins. Since the fungi responsible for the production of these mycotoxins are often endophytes that infect and colonise living plant tissues, accumulation of mycotoxins in the plant tissues may at times be associated with development of plant disease symptoms. The presence of mycotoxins, even in the absence of disease symptoms, may still have subtle biological effects on the physiology of plants. This review examines the question of whether or not the knowledge gained from mechanistic studies and development of biomarkers in animal and human systems is transferable to the study of mycotoxin effects on plant systems. Thus far, fumonisin has proven amenable to development of mechanism-based biomarkers to study maize seedling disease caused by the fumonisin producer, Fusarium verticillioides. Expanding our knowledge of mechanisms of toxicity and the overt and subtle effects on animal, human, and plant systems through the identification and validation of biomarkers will further our ability to monitor and limit the damage and economic impact of mycotoxins.
Collapse
Affiliation(s)
- T. Baldwin
- Toxicology and Mycotoxin Research Unit, USDA, ARS, 950 College Station Road, Athens GA 30605, USA
- Department of Plant Pathology, University of Georgia, 2105 Miller Plant Science Building, Athens GA 30602-7274, USA
| | - R. Riley
- Toxicology and Mycotoxin Research Unit, USDA, ARS, 950 College Station Road, Athens GA 30605, USA
| | - N. Zitomer
- Toxicology and Mycotoxin Research Unit, USDA, ARS, 950 College Station Road, Athens GA 30605, USA
| | - K. Voss
- Toxicology and Mycotoxin Research Unit, USDA, ARS, 950 College Station Road, Athens GA 30605, USA
| | - R. Coulombe Jr.
- Department of Veterinary Sciences, Utah State University, 4815 Old Main Hill, Logan UT 84322-4620, USA
| | - J. Pestka
- Department of Food Science and Human Nutrition, Michigan State University, 234 GM Trout Building, East Lansing MI 48824-1224, USA
| | - D. Williams
- Department of Environmental and Molecular Toxicology, Oregon State University, 1007 Agriculture & Life Sciences Building, Corvallis, OR 97331, USA
| | - A. Glenn
- Toxicology and Mycotoxin Research Unit, USDA, ARS, 950 College Station Road, Athens GA 30605, USA
| |
Collapse
|
153
|
Abstract
There is growing recognition and interest in the role of mycotoxins as health hazards in the workplace. Examples will illustrate what we know about certain mycotoxins in some occupational settings and what we need to know to make further progress in assessing their impact on human health. A range of mycotoxins has been detected in different workplaces, e.g. in agricultural and food processing facilities, greenhouses, and the waste management sector. Their occurrence, mainly in dust from different raw materials or processed products, is indicative of a potential health hazard. However, assessing risks for workplace-related mycotoxin exposures remains a challenging task for several reasons, including uncertainties with regard to the transfer from contaminated material into air (inhalable mycotoxin concentrations) and/or the toxin fraction absorbed upon dermal contact or after respiratory intake. Human biomonitoring studies can considerably reduce these uncertainties, and serve to assess workplace-related exposures (in addition to dietary mycotoxin intake). These studies require not only sensitive methods for analysis of mycotoxins and/or their metabolites in blood or urine (biomarkers of exposure) in a cohort of workers, but also data on the levels/range of these biomarkers in non-occupationally exposed persons to account for exposures resulting from oral intake of mycotoxin-contaminated food (dietary 'background'). Biomonitoring methods were first developed for aflatoxin B1, then for ochratoxin A, and more recently for deoxynivalenol and for fumonisin B. But, there are no such methods for many other important mycotoxins. So far, only a small number of biomonitoring studies have addressed the question whether occupational mycotoxin exposures (by inhalation) add significantly to those from dietary exposure to mycotoxins, as observed in the general population. Therefore, a risk assessment is hampered by major uncertainties regarding the true impact of occupational mycotoxin exposures. Human biomonitoring (with biomarkers of exposure and/or effect) is considered a valuable instrument, and should be developed further for mycotoxins of relevance in the workplace.
Collapse
Affiliation(s)
- G. Degen
- Leibniz Research Centre for Working Environment and Human Factors, University of Dortmund (IfADo), Ardeystrasse 67, 44139 Dortmund, Germany
| |
Collapse
|
154
|
Direct quantification of deoxynivalenol glucuronide in human urine as biomarker of exposure to the Fusarium mycotoxin deoxynivalenol. Anal Bioanal Chem 2011; 401:195-200. [DOI: 10.1007/s00216-011-5095-z] [Citation(s) in RCA: 54] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2011] [Revised: 05/10/2011] [Accepted: 05/10/2011] [Indexed: 10/18/2022]
|
155
|
Maragos CM. Detection of deoxynivalenol using biolayer interferometry. Mycotoxin Res 2011; 27:157-65. [PMID: 23605795 DOI: 10.1007/s12550-011-0090-y] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2010] [Revised: 01/24/2011] [Accepted: 01/26/2011] [Indexed: 11/29/2022]
Abstract
Biolayer interferometry allows for the real time monitoring of the interactions between molecules without the need for reagents with enzymatic, fluorescent, or radioactive labels. The technology is based upon the changes in interference pattern of light reflected from the surface of an optical fiber when materials bind to the tip of the fiber. The technique represents an alternative to technologies such as surface plasmon resonance, with an advantage in that the flow of extracts through small capillaries is not required. In this report, a deoxynivalenol-bovine serum albumin (DON-BSA) conjugate was non-covalently immobilized to the surface of aminopropylsilane sensors and the change in interference pattern resulting from the binding of DON-specific antibodies was measured. The basis for the assay was the competition between DON and the immobilized DON-BSA for binding to limited amounts of antibody. The technique was used to measure DON in extracts of spiked whole wheat flour, with a limit of detection of 0.10 mg DON/kg. Matrix interferences were an issue, and adequate quantification required using matrix-matched standards. When samples were tested with sensors that had not been conditioned to remove loosely attached DON-BSA, the recoveries at five spiking levels over the range from 0.2 to 5 mg/kg averaged 108.8% [relative standard deviation (RSD) 16.0%]. Using sensors that had been conditioned lowered the average recovery (101.4%) and improved the RSD (13.2%). This suggests that conditioning the sensors helped reduce a bias in the assay towards overestimation. These results, and the ease with which assays can be conducted, suggest further exploration of this technology for detection of mycotoxins is warranted.
Collapse
Affiliation(s)
- Chris M Maragos
- Bacterial Foodborne Pathogens and Mycology Research Unit, National Center for Agricultural Utilization Research, Agricultural Research Service, United States Department of Agriculture, 1815 N. University Street, Peoria, IL 61604, USA.
| |
Collapse
|